PolitiKit

Consultant In effect since Jun 18, 2025

Consultant Jared Maltais of Wellington Advocacy

Consultant lobbyists

• Jared Maltais Former public office holder

  Formerly Legislative Assistant, Office of the Member of Parliament for Ottawa Centre, House of Commons (2022–2024)

Institutions they may lobby: Agriculture and Agri-Food Canada (AAFC), Canada Revenue Agency (CRA), Canadian Institutes of Health Research (CIHR), Canadian International Trade Tribunal (CITT), Environment and Climate Change Canada (ECCC), Fisheries and Oceans Canada (DFO), Global Affairs Canada (GAC), Health Canada (HC), House of Commons, Innovation, Science and Economic Development Canada (ISED), Justice Canada (JC), National Research Council (NRC), Natural Resources Canada (NRCan), Natural Sciences and Engineering Research Council (NSERC), Patented Medicine Prices Review Board (PMPRB), Prime Minister's Office (PMO), Privy Council Office (PCO), Public Health Agency of Canada (PHAC), Public Services and Procurement Canada (PSPC), Senate of Canada, Statistics Canada (StatCan), Treasury Board Of Canada Secretariat (TBS), Veterans Affairs Canada (VAC)

What they're lobbying on (16)Hide details

• Biomanufacturing and Life Sciences Strategy (BLSS) as it relates to the biopharmaceutical industry
• Patent Act as it relates to reporting requirements and pricing guidelines, and the protection of intellectual property in biopharmaceutical products
• Canada's Access to Medicines Regime with respect to ensuring that the program allows for the delivery of timely access to needed medicines to the developing world supported by a business climate in Canada that continues to encourage research into further treatment and prevention of disease
• Patented Medicines (Notice of Compliance) Regulations as it relates to the regulation of intellectual property for biopharmaceutical products
• Canadian Institutes of Health Research (CIHR) Clinical Research Initiative as it relates to public/private research and development partnerships
• Proposed pharmacare legislation related to any future national pharmacare program
• Annual federal Budgets and Budget updates as it relates to the biopharmaceutical industry
• Pharmaceutical pricing policy issues arising from the jurisdiction of the Patented Medicines Prices Review Board (PMPRB)
• Common Drug Review Policies as it relates to reimbursement recommendation decision-making process and framework
• Food and Drug Regulations as it relates to data protection and the regulation and protection of biopharmaceutical products
• Food and Drugs Act and Regulations and the Import and Export Permits Act with respect to cross-border trade as it relates to the export of Canadian biopharmaceuticals
• Free trade treaty agreement as they relate to The Canada-United States-Mexico Agreement (CUSMA) and free trade negotiations as it relates to India, the European Union, Japan, MERCOSUR and the Trans-Pacific Partnership
• Scientific Research and Experimental Development (SR&ED) Tax Credit in respect of updating the system and increasing the expenditure limit for refundable credits
• Patented Medicines Regulations as it relates to the regulation and protection of biopharmaceutical products
• Patented Medicines (Notice of Compliance) Regulations with respect to ensuring that patent rights are respected and are internationally competitive
• Canadian Environmental Protection Act and Regulations in respect of modern, science-based regulations to reflect rapidly changing new technologies

Registration 950970-381425-1. Look it up in the official Registry